Japan-Watching: Ministry of Foreign Affairs of Japan

First Meeting of the Study Group on Strengthening Japan-Africa Economic Partnership

At TICAD 9 held last August, Mr. ISHIBA Shigeru (石破 茂), then Prime Minister of Japan, announced the establishment of the “Study Group on Strengthening JapanAfrica Economic Partnership” as one of the concrete initiatives of the Japanese Government’s policy on Africa. The first meeting of this study group is scheduled for June 18 in a hybrid format.

Under the framework of a “Free and Open Indo-Pacific (FOIP)”, this study group will address African economic integration, a top priority for the African Union (AU). Through strengthening economic cooperation between Japan and Africa, the study group aims to support business expansion of Japanese companies in the African market. To this end, the study group will discuss various topics including measures to promote regional economic integration in Africa, review of trade and investment between Japan and Africa, and the strengthening of economic relations between Japan and Africa. The study group will prepare a report by the end of the fiscal year 2027, which will be submitted to the Minister for Foreign Affairs.

(Reference 1) Japanese Members

Prof. WATANABE Yorizumi (渡邊 頼純), Professor Emeritus, Keio University; Dr. KIMURA Fukunari (木村 福成), President, JETRO Asian Economic Research Institute; Mr. FUJITA Ryoji (藤田 亮二), Executive Officer, Toyota Tsusho Corporation (Representative from Keidanren); WATANABE Tatsuro (渡邉 達郎), Managing Executive Officer, Mitsui O.S.K. Lines (Representative from Keizai Doyukai); IGARASHI Katsuya (五十嵐 克也), Director and Head of International Department, the Japan Chamber of Commerce and Industry; and representatives from the Ministry of Foreign Affairs, Ministry of Finance, Ministry of Agriculture, Forestry and Fisheries, and Ministry of Economy, Trade and Industry.

(Reference 2) African Members

Mr. Lacina Koné, Director General and CEO, Smart Africa Alliance; Mr. Kulekani Mathe, CEO, Business Unity South Africa (BUSA); Dr. E. Olawale Ogunkola, Professor of Economics, University of Ibadan, Nigeria; and representatives from the United Nations Economic Commission for Africa (UNECA), the African Continental Free Trade Area (AfCFTA) Secretariat, and the African Union Commission (AUC).

(Note) In addition, relevant Ministries, agencies, and individuals with expertise are expected to attend depending on the agenda.

(Reference 3) Attachment

Establishment of the Study Group on Strengthening Japan-Africa Economic Partnership [Archived PDF]

G7 Evian Summit

Working Session on “Reviving a Balanced, Shared and Sustainable Economic Growth”

On June 17, commencing at 10:30 a.m. (local time. 5:30 p.m. on June 17, Japan time.) for approximately 120 minutes, Ms. TAKAICHI Sanae (高市 早苗), Prime Minister of Japan, attended the G7 Evian Summit Working Session on “Reviving balanced, inclusive, and sustainable economic growth for the benefit of all”. The overview of the session is as follows.

  1. Prime Minister TAKAICHI stated that the G7 and like-minded countries should maintain close communication to reduce uncertainty in the global economy.
    Prime Minister TAKAICHI also stated that it is a common challenge for many countries to promote self-sustaining growth, by addressing non-market policies and practices (NMPPs) and the resulting excess capacity which are drivers of widening global imbalances.
  2. Furthermore, Prime Minister TAKAICHI stated that G7 members and the countries participating in this session should also demonstrate their contribution to reducing imbalances for their own balanced growth as well as for the stability of the global economy and financial markets. Prime Minister TAKAICHI added that making use of data-driven, objective analyses and policy advice by the IMF and the OECD is extremely beneficial in advancing these efforts.
  3. Prime Minister TAKAICHI expressed her hope that the G7 and like-minded countries would lead the global economy through frank discussions. She also stated that she looked forward to discussions at the G20, chaired by President Donald Trump of the United States, on reducing uncertainty in the global economy and becoming stronger and more prosperous together.

Situation in Iran (Signing of a Memorandum of Understanding between the United States and Iran)

(Message from Foreign Minister MOTEGI Toshimitsu [茂木 敏充])

On June 18 (Japan Standard Time), the United States and Iran signed a Memorandum of Understanding and the cessation of hostilities was declared. Japan once again welcomes the fruition of the diplomatic efforts made by the parties as well as the countries that played a role in mediation.

Hereafter, it is important that free and safe navigation through the Strait of Hormuz is swiftly reestablished through the steady implementation of this MoU by all parties. Japan also considers it of critical importance that vessels be able to transit the Strait of Hormuz without being subject to additional costs, as has been the case thus far.

Japan strongly hopes that a final agreement on matters such as Iran’s nuclear issue will be achieved as soon as possible through further negotiations between the United States and Iran. Japan will also support the peaceful resolution of the Iranian nuclear issue including through coordination with the International Atomic Energy Agency (IAEA).

After the conclusion of a final agreement, Japan intends to play an active role in the reconstruction and recovery of the region. Japan will also continue to make every diplomatic effort, in close coordination with the international community, toward the realization of peace and stability throughout the Middle East region.

Parliamentary Vice-Minister for Foreign Affairs ERI’s Visit to the United States

From June 21 to June 24, Ms. ERI Arfiya (英利 アルフィヤ), Parliamentary Vice-Minister for Foreign Affairs of Japan, will visit New York, United States.

During her visit, Parliamentary Vice-Minister ERI will attend the United Nations General Assembly High-Level Meeting on HIV/AIDS and deliver a statement in the meeting. She will also hold meetings with representatives of international organizations.

(Reference) Schedule
June 21Departure from Tokyo
 Arrival at New York
June 22Participation in the United Nations General Assembly High-Level Meeting on HIV/AIDS, etc.
June 23Meetings with representatives of international organizations, etc.
 Departure from New York
June 24Arrival at Tokyo

The 7th Japan-Australia Cyber Policy Dialogue

On June 18, the 7th JapanAustralia Cyber Policy Dialogue was held in Tokyo, Japan.

  1. This whole-of-government meeting was co-chaired by Mr. MIYAKE Fumito (三宅 史人), Ambassador in charge of Cyber Policy and Deputy Director-General of the Foreign Policy Bureau, Ministry of Foreign Affairs (MOFA) of Japan, and Ms. Jessica Hunter, Ambassador for Cyber Affairs and Critical Technology, Department of Foreign Affairs and Trade (DFAT), Australia, with the participation of officials from, on the Japanese side, MOFA, National Cybersecurity Office (NCO), National Police Agency (NPA), Ministry of Defense (MOD), Ministry of Internal Affairs and Communications (MIC) and Ministry of Economy, Trade and Industry (METI), and on the Australian side, DFAT, Department of Industry and Australian Signals Directorate (ASD)’s Australian Cyber Security Centre (ACSC) and Department of Home Affairs (DHA).
  2. At this dialogue, following the enactment of Japan’s Cyber Response Capability Strengthening Act and Necessary Arrangement of Relevant Acts last year, as well as the adoption of its new Cybersecurity Strategy, the two sides exchanged views on broad range of topics, such as each country’s respective cybersecurity strategy and policy, and cooperation at both the bilateral and multilateral levels.
  3. Furthermore, building on the “JapanAustralia Strategic Cyber Partnership” which Ms. TAKAICHI Sanae (高市 早苗), Prime Minister of Japan and the Hon. Anthony Albanese, Prime Minister of Australia concurred on launching at the JapanAustralia Summit Meeting in May of this year, the two sides exchanged views on efforts and cooperation in a wide range of areas including the defense and deterrence of cyber threats, capacity-building, public-private partnerships, and artificial intelligence (AI) and cybersecurity.
  4. Both sides confirmed that they will continue to work closely together in the field of cyber, including through the JapanAustralia Cyber Policy Dialogue.

[from the Ministry of Foreign Affairs of Japan, 18-19 June, 2026]

“2022 Monkeypox Outbreak: Situational Awareness” with Syra Madad [Zoom]

[from Harvard Kennedy School’s Belfer Center, part of Harvard University]

Thursday, July 21, 2:30-4:00 PM EDT

RSVP (Required)

The 2022 Monkeypox outbreak continues to expand with case counts mounting in many countries. This seminar will cover where we are in the global fight against monkeypox, where we may be headed as a nation, and what we need to do right now to mitigate the growing threat of monkeypox. Join Belfer Fellow Dr. Syra Madad in conversation with Kai Kupferschmidt, Dr. Krutika Kuppalli, Dr. Anne Rimoin, Dr. Boghuma Kabisen Titanji, and Dr. Jay K. Varma.

About the Speakers

Dr. Anne Rimoin is a Professor of Epidemiology at the UCLA Fielding School of Public Health. She is the Gordon-Levin Endowed Chair in Infectious Diseases and Public Health. Dr. Rimoin is the director of the Center for Global and Immigrant Health and is an internationally recognized expert on emerging infections, global health, surveillance systems, and vaccination.

Rimoin has been working in the DRC since 2002, where she founded the UCLA-DRC Health Research and Training Program to train U.S. and Congolese epidemiologists to conduct high-impact infectious disease research in low-resource, logistically-complex settings.

Dr. Rimoin’s research focuses on emerging and vaccine-preventable diseases. It has led to fundamental understandings of the epidemiology of human monkeypox in post-eradication of smallpox, long-term immunity to Ebola virus in survivors and durability of immune response to Ebola virus vaccine in health workers in DRC. Her current research portfolio includes studies of COVID-19, Ebola, Marburg, Monkeypox and vaccine-preventable diseases of childhood.

Boghuma Kabisen Titanji (MD, MSc., DTM&H, PhD) is a Cameroonian born physician-scientist and Assistant Professor of Medicine at Emory University in Atlanta. She obtained her MD from the University of Yaoundé I in Cameroon and worked for two years after graduation as a medical officer, before pursuing post-graduate research training in London, United Kingdom. As an awardee of the prestigious Commonwealth Scholarship program, she obtained a Masters Degree in Tropical Medicine and International Health from the London School of Hygiene and Tropical Medicine, a diploma in Tropical Medicine and Hygiene from the Royal College of Physicians and a Ph.D. in Virology from University College London. Dr. Titanji joined Emory University School of Medicine in 2016 where she completed a residency in Internal Medicine, on the ABIM research pathway and a fellowship Infectious Diseases. She has three parallel career interests: translational and clinical research in HIV and emerging virus infections, science communication, and global health. Her clinical focus is general infectious diseases and people with HIV. Her current research focuses on chronic inflammation as a mediator of cardiovascular disease in people with HIV. She is passionate about leveraging translational research to improve the care of people with HIV, global health equity and using science to influence health policy through science communication and advocacy.

Jay K. Varma, MD is a Professor of Population Health Sciences and Director of the Cornell Center for Pandemic Prevention and Response at Weill Cornell Medicine. Dr. Varma is an expert on the prevention and control of diseases, having led epidemic responses, developed global and national policies, and led large-scale programs that have saved hundreds of thousands of lives in China, Southeast Asia, Africa, and the United States. After graduating magna cum laude with highest honors from Harvard, Dr. Varma completed medical school, internal medicine residency, and chief residency at the University of California, San Diego School of Medicine. From 2001-2021, he worked for the U.S. Centers for Disease Control and Prevention with postings in Atlanta, Thailand, China, Ethiopia, and New York City. From April 2020 – May 2021, he served as the principal scientific spokesperson and lead for New York City’s COVID-19 response. Dr. Varma has authored 143 scientific manuscripts, 13 essays, and one book.

Kai Kupferschmidt is a science journalist based in Berlin, Germany. He is a contributing correspondent for Science where he often covers infectious diseases. Kai received a diploma in molecular biomedicine from the University of Bonn, Germany and later visited the Berlin Journalism School. He has won several awards for his work, including the Journalism Prize of the German AIDS Foundation. Together with two colleagues he runs a podcast on global health called Pandemia [German]. He has also written two books, one about infectious diseases and one about the science of the color blue.

Krutika Kuppalli, MD, FIDSA is a Medical Officer for Emerging Zoonotic Diseases and Clinical Management in the Health Emergencies Program at the World Health Organization where she currently supports activities for the Monkeypox outbreak and COVID-19 pandemic. She completed her Internal Medicine residency and Infectious Diseases fellowship at Emory University, a Post-Doctoral Fellowship in Global Public Health at the University of California, San Diego and the Emerging Leader in Biosecurity Fellowship at the Johns Hopkins Center for Health Security. Dr. Kuppalli currently serves on the American Society of Tropical Medicine and Hygiene (ASTMH) Trainee Committee and is the Chair of the Infectious Diseases Society of America (IDSA) Global Health Committee.

Dr. Kuppalli was previously awarded the NIH Fogarty International Clinical Research Fellowship and conducted research in Southern India to understand barriers to care and how emerging infections impacted persons living with HIV/AIDS. She was the medical director of a large Ebola Treatment Unit in Sierra Leone during the 2014 West Africa Ebola outbreak, helped lead the development and implementation of pandemic response preparedness activities in resource limited settings, and has consulted on the development of therapeutics for emerging pathogens. Her clinical and research interests focus on health systems strengthening in resource limited settings, research and clinical care for emerging infections, outbreak preparedness and response, and policy. She has worked in numerous countries including Ethiopia, India, Sierra Leone, Uganda, and Haiti.

During the COVID-19 pandemic Dr. Kuppalli served as a consultant for the San Francisco Department of Health and helped develop and operationalize a field hospital. She served as an expert witness to the U.S. Congress, Financial Services Committee Task Force on Artificial Intelligence (AI) about how digital technologies may be leveraged for exposure notification and contact tracing to improve the pandemic response. She also collaborated with the Brennan Center for Justice to develop guidelines to inform “Healthy in-person Voting” in advance of the 2020 U.S. election and testified before the U.S. House Select Subcommittee regarding these recommendations. Prior to her position at WHO, she was the medical lead for COVID-19 vaccine rollout at the Medical University of South Carolina (MUSC) and helped coordinate vaccine education events for the staff and community and oversaw the reporting of adverse vaccine events.

Since joining WHO in August 2021, Dr. Kuppalli has been part of the WHO headquarters incident management team (IMST) for COVID-19, the clinical characterization and management working group for COVID-19, the COVID-19 therapeutics steering committee, and is the technical focal point for the post COVID-19 condition (Long COVID) steering committee. She is a member of the secretariat on the scientific advisory group on the origins of emerging and re-emerging infectious diseases (SAGO) which was convened by the Director General to understand and investigate the origins of SARS-CoV-2 and other novel pathogens. More recently since the development of the multi-country monkeypox outbreak she has been part of the IMST at WHO as one of the clinical management focal points. In this capacity she was part of the WHO core group that helped write the recently published Clinical Management and Infection Prevention and Control guidelines for Monkeypox and advising on the clinical endpoints for the global CORE therapeutics protocol.

Dr. Kuppalli is recognized as a scientific expert in global health, biosecurity and outbreak response. She was recognized by NPR Source of The Week early in the pandemic as an expert to follow and named to Elemental’s 50 Experts to Trust in a Pandemic. She has been a frequent contributor to numerous domestic and international media outlets including The New York Times, NPR, Reuters, The Washington Post, Vox, Stat News, San Francisco Chronicle, Forbes, NBC Bay Area, BBC News.